CenExel HRI’s Dr. Cohen

Dr. Elan Cohen, Principal Investigator at CenExel Marlton, joined Good Morning Washington to discuss how clinical research is driving the next generation of mental health treatments. He highlighted the continued rise of challenges such as opioid addiction, Alzheimer’s disease, and limited access to care—along with how CenExel is advancing new investigational therapies to address them. Dr. Cohen also explored innovations underway at CenExel’s nationwide sites, including long-acting medications for opioid use disorder, immune-targeted approaches for Alzheimer’s, and emerging options for depression and anxiety. He emphasized the importance of personalized well-being strategies, the realities of study participation, and the growing role of AI in mental health, offering viewers a forward-looking perspective on the future of care.